Piriformis Muscle Syndrome
Conditions
Keywords
piriformis syndrome, steroid injection, dry needling, exercise
Brief summary
The aim of this study is to to compare its effectiveness ultrasound-guided steroid injection, dry needling treatments and exercises in patients diagnosed with piriformis syndrome.
Detailed description
Piriformis syndrome is a painful entrapment neuropathy caused by compression of the sciatic nerve under the piriformis muscle. The most common cause is myofascial pain syndrome. There is no gold standard treatment for piriformis syndrome. The main purpose of treatment methods is to reduce local pain, muscle tension and spasm. This work; it will contribute to the literature by comparing steroid, dry needling and exercise treatments in patients with piriformis syndrome.
Interventions
OTHERcorticosteroid injection
In the steroid group, 4 mL lidocaine 2% + 1 mL betamethasone injection will be administered under ultrasound guidance and conventional treatment will be given (conventional treatment includes piriformis stretching exercises. It will be stated that patients should do 2 sets a day and each set should be 10 repetition)
OTHERdry needling
In the dry needling group, a total of 3 sessions of dry needling will be performed once a week using a 0.60×100 mm sterile needle under ultrasound guidance and conventional treatment will be given ((conventional treatment includes piriformis stretching exercises. It will be stated that patients should do 2 sets a day and each set should be 10 repetition)
OTHERexercise
The conventional treatment group (control group) will be given piriformis stretching exercises including hip and knee flexion, hip abduction and external rotation in the supine position. It will be stated that patients should do 2 sets a day and each set should be 10 repetitions.
Sponsors
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
Outcome measures will be evaluated by an independent physiatrist, blinded for the assigned treatment.
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. Age between 18-60, 2. Hip pain for ≥1 month 3. Local piriformis pain with prolonged sitting (\>20 minutes) and increased sensitivity 4. Patients with suspected piriformis syndrome based on clinical maneuvers 5. Signing and informed consent from showing consent to participate in the study
Exclusion criteria
1. Hip surgery 2. Lumbar disc disease 3. History of inflammatory hip disease 4. Medical treatment for pain is started 5. Neurological deficit 6. Breastfeeding or pregnant 7. Allergy to local anesthetic 8. Use of anticoagulants 9. Body mass index \>35 10. Active psychiatric illness 11. Uncontrolled hypertension and diabetes mellitus disease 12. Noncompensated chronic lung/heart/renal failure 13. History of vascular/tumoral disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analogue Scale (VAS) (Sitting) | at baseline and change from baseline VAS (sitting) at 4 weeks and 12 weeks | Average hip pain intensity in a sitting position over the past 24 hours, a visual analog scale. (VAS; ranging from 0 to 10, 0 = no pain and 10 = worst possible pain) |
| Visual Analog Scale (VAS) (Resting) | at baseline and change from baseline VAS (resting) at 4 weeks and 12 weeks | Average hip pain intensity at rest over the past week is a visual analog scale. (VAS; ranging from 0 to 10, 0 = no pain and 10 = worst possible pain) |
| Visual Analog Scale (VAS) (Movement) | at baseline and change from baseline VAS (movement) at 4 weeks and 12 weeks | Average hip pain intensity during movement over the past 1 week is a visual analog scale. (VAS; ranging from 0 to 10, 0 = no pain and 10 = worst possible pain) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Oswestry disability index (ODI) | at baseline and change from baseline ODI at 4 weeks and 12 weeks | ODI includes questions regarding pain severity, sexual function, sleep quality and personal care, ability to work, sit, walk, lift, stand and travel. Total score ranges from 0-50, with higher scores indicating more injury. |
Contacts
Primary ContactAyşenur Şimşek Yağlıoğlu, MD
Outcome results
None listed